Intraosseous Infusion Devices Market (2023 to 2033)

The intraosseous infusion devices market size is projected to be valued at US$ 4.4 billion in 2023 and is expected to rise to US$ 8.6 billion by 2033. The sales of intraosseous infusion devices are expected to grow at a significant CAGR of 6.9% during the forecast period. Various factors propelling the demand for intraosseous infusion devices are:

  • The global intraosseous infusion devices market is steadily expanding, owing primarily to an increase in the number of emergency medical cases and a high incidence of chronic disorders all of which increase the likelihood of hospitalization.
  • Furthermore, increased physician and patient awareness of newly introduced treatment procedures and technologies, as well as significant government investments in technologies adopted for easy and rapid drug administration, are supporting market growth.
  • Vendors will have tremendous growth potential as a result of rising demand for intraosseous devices in emergency and military medical facilities as well as the introduction and enforcement of legislation and standards.
  • However, difficulties including fewer intraosseous infusion device applications, a lack of information regarding intraosseous infusion devices, and complications related to intraosseous infusion may obstruct market participants' growth.
  • Manufacturers are investing in Research and Development (R&D) to create IO devices that can be used in hospital settings to initiate immediate care for patients. Mergers and acquisitions, as well as extensive R&D initiatives to strengthen product portfolios, are key strategies used by businesses to increase revenue.
Attributes Details
Intraosseous Infusion Devices Market CAGR 6.9%
Intraosseous Infusion Devices Market Valuation (2023) US$ 4.4 billion
Intraosseous Infusion Devices Market Valuation (2033) US$ 8.6 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How is Rising Demand for Emergency Healthcare Affecting Intraosseous Infusion Devices Market?

  • IO Devices are designed to maximize efficiency, and safety, eliminate unnecessary services, and decrease treatment time. A sedentary lifestyle has also determined the growth of the market as it causes various illnesses which include, last-stage renal diseases, COPD, urological diseases, cardiovascular diseases, etc. Such chronic clinical conditions have brought demand for vascular access devices in the forecast period.

Emergency medical care is considered as pre-hospital or ambulatory transportation aid for road accident victims and those who have sustained life-threatening injuries for which, immediate medical intervention is required. The lack of structural models in medical aid leads to ineffective medical care. These factors, along with the rising number of emergency cases globally are expected to raise demand for efficient emergency medical services and in turn, are underpinning the intraosseous infusion device market.

According to the American Heart Association report, 2015, compiled with data from the Centers for Disease Control and Prevention, the National Institutes of Health, and other government sources, cardiovascular disease is the leading cause of death globally, associated with 17.3 million deaths per year, which is further expected to increase to 23.6 million by 2030 end.

Vascular access products fill an important void in emergency medical services and contribute significantly towards the annual revenue of various major medical device manufacturers. The ease and immediate effect through vascular access have helped considerably high number of patients requiring immediate medication intervention.

According to an Elsevier/Journal of Emergency Medical Services (JEMS) editorial supplement sponsored by VidaCare, IO infusion supported vascular access to drugs positively and provided rapid vascular access in 250 patients with a success rate of 97%. The study supports the significance of the need for vascular access and is expected to favor the growth of the intraosseous infusion market shortly

Over recent years, there has been a significant upsurge in the number of emergency medical cases in response to rising demand from patients, physicians, and insurers. Rapid technological advancements have led to various medical procedures being carried out using vascular access devices.

How will the Intraosseous Infusion Market Outlook for 2023 to 2033 compare to 2017 to 2022?

According to Future Market Insights (FMI), the sales of the intraosseous infusion device have grown at a CAGR of nearly 7.2% between 2017 and 2022. Increasing research on emergency medical care portfolios globally will result in impressive sales prospects over the coming years.

According to FMI, the intraosseous infusion devices market holds nearly 19% of the US$ 18.5 billion worth global market for infusion devices. The demand for intraosseous devices will continue increasing through the forecast period.

For instance, air support for immediate medical emergency services is the new outlook in 911 services and has been appreciated by other emergency health professionals and the local population.

The upcoming air emergency medical service is to be equipped with a variety of emergency medical devices such as a ventilator, cardiac monitor, burn packs, IV pumps, cervical collars, and obstetric kit along with intraosseous infusion devices.

The upcoming policy is expected to drive the intraosseous infusion devices market. Infusion of drugs through the bone using intraosseous devices is more cost effective and can be done more efficiently as compared to intravenous catheters in hospital settings.

Manufacturers are investing in research and development activities to develop IO devices that can be used in hospital settings to initiate instant care to patients. Mergers and acquisitions together with extensive R&D initiatives for strengthening product portfolios are key strategies adopted by companies to increase their revenue.

For Instance, On Dec 18, Cook Medical Incorporated announced the acquisition of Whitaker Park Development Authority Inc. once manufactured cigarettes but henceforth will be manufacturing intraosseous infusion devices for better care of the patients.

The market is consolidated and is dominated by players such as include, Pyng Medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Co.

Future Market Insights expects the global market for intraosseous infusion devices to grow at a CAGR of 6.9% between 2023 and 2033. The growth is attributable to the rising number of research and development activities undertaken by market players to expand their presence and strengthen product portfolios.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How is The Rising Number of Traumatic Surgeries Affecting Intraosseous Infusion Devices Market Growth?

There are two components involved in community care, care during transportation and care in the healthcare facility. In emergency medical departments a patient can be brought in with a severe life-threatening condition, be it severe burns, road traffic accidents, or cardiac arrest, where sometimes it is difficult to find an IV point or it becomes difficult when the venous system is collapsed. This in turn is the need for intraosseous infusion devices in the market.

A rising number of traumatic surgeries especially in pediatric patients has been reported in the past few decades, which is further expected to support the intraosseous infusion devices-based market growth.

According to the Royal College of Surgeons, 2014, a document on emergency surgery policy briefing states that approximately 25% of patients were admitted in an emergency from 2012 to 2013 with 32% of trauma and orthopedic surgery collectively. The rate of patient readmission increased by 27.1% from 2002 to 03 to reach 11.5% in 2012 to 13

The American College of Surgeons Advanced Trauma Life Support Manual (ATLS) 1997, has suggested the use of intraosseous infusion in children up to 6 years of age during traumatic situations like a circulatory failure or after two failed attempts of intravenous access.

Country-wise Insights

Will the USA Intraosseous Infusion Devices Market Continue Leading North America?

Due to the increasing use of I.O., North America was identified as the leading geographical region with a market size of USD 1.2 billion in the intraosseous devices market with the USA being its front-runner. The rising prevalence of various chronic diseases, the increasing number of traumatic surgeries, and high military consumption, particularly during wartime are pushing the market towards a growth trajectory.

Why is Germany's Intraosseous Infusion Devices Market Considered Highly Lucrative within Europe?

Germany is expected to grow at a rate of 6.3% over the period of 2023-2033. This is due to the increasing aging population, rising cases of chronic diseases, and the presence of well-established centers which provide quality care. Furthermore, favorable regulatory scenarios are likely to offer exciting opportunities for the intraosseous infusion device in Germany.

China to grow over 6.5% during 2023-2033

The Asia Pacific market is expected to account for over 34% of the market share through the forecast period. The increasing use of IO Devices, with advancements in technology, expansion of the healthcare industry, and the rising need for efficient and safe healthcare practices and other therapeutics are the primary factors driving growth in China.

Sales in China are also influenced by domestic market impact factors such as regulatory change, favorable government policies, and growing funding which affect current and future market trends.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Why is the demand for EZ-IO Product Rising?

In terms of product, EZ-IO intraosseous infusion devices hold the maximum share of over 20% in 2021, expanding at 6.4% CAGR during the forecast period. The growth registered in this category is due to its quick response and surety of easy intraosseous accessibility within 30 seconds.

Why is the Sternum Route of Administration Preferred in the Intraosseous Infusion Devices Market?

In terms of route of administration, the Sternum segment accounts for 30.8% of the market share in 2021, indicating the prevalence of high demand for high-quality care specificity when compared with the Distal & Proximal Tibia. This trend is expected to continue during the forecast period as well.

How Will Sales of Automatic Intraosseous Infusion Devices Fare?

By technology, the automatic infusion devices market accounts for 50.8% of the market share in 2021, expanding at a rate of 6.00%. The demand in this segment will continue to rise. It is primarily preferred by patients when they need instant care.

Who is the Leading End User of Intraosseous Infusion Devices?

By end user, EMS and hospitals together will account for more than 60.0% of the market share in 2021. The rising demand for IO devices with various advancements and harnessing new scientific advances is likely to fuel the segment.

Intraosseous Infusion Devices Industry Competitive Landscape

Companies that manufacture intraosseous infusion devices are actively seeking to strengthen their position through various strategic planning initiatives such as collaborations, merger and acquisition partnerships, FDA approvals, and agreements with both established and emerging market players. These strategies will assist manufacturers in capitalizing on market opportunities. The greater the demand for active service, the stronger the end product, resulting in increased market demand. Leading industry players are concentrating their efforts on the creation and launch of a technologically advanced service portfolio. There are numerous opportunities for market participants to invest in intraosseous infusion devices.

Aero Healthcare acquired Clayton First Aid in July 2020, opening the door for them to expand into intraosseous infusion devices.

Major Players Covered in the Market

  • Pyng Medical Corp.
  • Biopsybell
  • Cook Medical Incorporated
  • PAVmed
  • PerSys Medical
  • Aero Healthcare
  • Teleflex, Inc.
  • Becton Dickinson and Company
  • SAM Medical
  • Cardinal Health, Inc.

Cook Medicals: Every medical discipline we support shares two fundamental themes: patients who want to get healthier and clinicians who want easier-to-use tools. For this reason, we put a lot of effort into developing, producing, and providing a distinctive portfolio of minimally invasive medical devices to healthcare systems all over the world.

Becton Dickinson and Company: With a product range that meets patients' demands, we seek to raise physician satisfaction while helping hospitals and surgery centers improve results and cut costs. For more than a century, BD has advanced surgical instrumentation and contributed to bettering outcomes. with a sizable portfolio and a track record for providing products of the highest caliber.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value
Key Countries Covered The USA, Canada, Germany, The United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Segments Covered By Product, By Route of Administration, By Technology, By End User, Region
Key Companies Profiled Pyng Medical Corp.; Biopsybell; Cook Medical Incorporated; PAVmed; PerSys Medical; Aero Healthcare; Teleflex, Inc.; Becton Dickinson and Company; SAM Medical; Cardinal Health, Inc.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Intraosseous Infusion Devices Market

By Product:

  • B.I.G
  • FAST1
  • EZ-IO
  • FASTR
  • IO Needles
  • Others

By Route of Administration:

  • Sternum
  • Distal & Proximal Tibia
  • Distal Femur
  • Calcaneus
  • Head of Humerus

By Technology:

  • Manual
  • Automatic
  • Impact Driven
  • Power Drill

By End User:

  • EMS
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

Frequently Asked Questions

How is the Intraosseous Infusion Devices Market Growing?

The Intraosseous Infusion Devices market is predicted to grow at 6.9% CAGR from 2023 to 2033.

What Drives the Intraosseous Infusion Devices Market?

High prevalence of chronic diseases and growing geriatric population

What is the Future Scope of Growth for the Intraosseous Infusion Devices Market?

The Intraosseous Infusion Devices market is expected to surpass US$ 8.6 billion by 2033.

What is the Current Intraosseous Infusion Devices Market Size?

The Intraosseous Infusion Devices market size is anticipated to be US$ 4.4 billion in 2023.

Table of Content
1. Executive Summary | Intraosseous Infusion Devices Market
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2022
    4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Product, 2017 to 2022
    5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
        5.3.1. B.I.G.
        5.3.2. FAST1
        5.3.3. EZ-IO
        5.3.4. FASTR
        5.3.5. IO Needles
        5.3.6. Others
    5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Route of Administration
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Route of Administration, 2017 to 2022
    6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Route of Administration, 2023 to 2033
        6.3.1. Sternum
        6.3.2. Distal & Proximal Tibia
        6.3.3. Distal Femur
        6.3.4. Calcaneus
        6.3.5. Head of Humerus
    6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017 to 2022
    6.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Technology, 2017 to 2022
    7.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Technology, 2023 to 2033
        7.3.1. Manual
        7.3.2. Automatic
            7.3.2.1. Impact Driven
            7.3.2.2. Power Drill
    7.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022
    7.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By End User, 2017 to 2022
    8.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
        8.3.1. EMS
        8.3.2. Hospitals
        8.3.3. Ambulatory Surgical Centers
        8.3.4. Cardiac Care Centers
    8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
    9.1. Introduction
    9.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2022
    9.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Western Europe
        9.3.4. Eastern Europe
        9.3.5. Asia Pacific excluding Japan (APEJ)
        9.3.6. Japan
        9.3.7. Middle East and Africa (MEA)
    9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
    10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. The USA
            10.2.1.2. Canada
        10.2.2. By Product
        10.2.3. By Route of Administration
        10.2.4. By Technology
        10.2.5. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product
        10.3.3. By Route of Administration
        10.3.4. By Technology
        10.3.5. By End User
    10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
    11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Brazil
            11.2.1.2. Mexico
            11.2.1.3. Rest of Latin America
        11.2.2. By Product
        11.2.3. By Route of Administration
        11.2.4. By Technology
        11.2.5. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By Route of Administration
        11.3.4. By Technology
        11.3.5. By End User
    11.4. Key Takeaways
12. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
    12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Germany
            12.2.1.2. France
            12.2.1.3. Italy
            12.2.1.4. Spain
            12.2.1.5. The United Kingdom
            12.2.1.6. BENELUX
            12.2.1.7. Rest of Western Europe
        12.2.2. By Product
        12.2.3. By Route of Administration
        12.2.4. By Technology
        12.2.5. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Route of Administration
        12.3.4. By Technology
        12.3.5. By End User
    12.4. Key Takeaways
13. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
    13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. Russia
            13.2.1.2. Poland
            13.2.1.3. Rest of Eastern Europe Europe
        13.2.2. By Product
        13.2.3. By Route of Administration
        13.2.4. By Technology
        13.2.5. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Route of Administration
        13.3.4. By Technology
        13.3.5. By End User
    13.4. Key Takeaways
14. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
    14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. ASEAN
            14.2.1.3. Australia
            14.2.1.4. Rest of APEJ
        14.2.2. By Product
        14.2.3. By Route of Administration
        14.2.4. By Technology
        14.2.5. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By Route of Administration
        14.3.4. By Technology
        14.3.5. By End User
    14.4. Key Takeaways
15. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
    15.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
        15.2.2. By Product
        15.2.3. By Route of Administration
        15.2.4. By Technology
        15.2.5. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product
        15.3.3. By Route of Administration
        15.3.4. By Technology
        15.3.5. By End User
    15.4. Key Takeaways
16. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    16.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
    16.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        16.2.1. By Country
            16.2.1.1. GCC Countries
            16.2.1.2. South Africa
            16.2.1.3. Rest of MEA
        16.2.2. By Product
        16.2.3. By Route of Administration
        16.2.4. By Technology
        16.2.5. By End User
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Product
        16.3.3. By Route of Administration
        16.3.4. By Technology
        16.3.5. By End User
    16.4. Key Takeaways
17. Key Countries Market Analysis
    17.1. the USA
        17.1.1. Pricing Analysis
        17.1.2. Market Share Analysis, 2022
            17.1.2.1. By Product
            17.1.2.2. By Route of Administration
            17.1.2.3. By Technology
            17.1.2.4. By End User
    17.2. Canada
        17.2.1. Pricing Analysis
        17.2.2. Market Share Analysis, 2022
            17.2.2.1. By Product
            17.2.2.2. By Route of Administration
            17.2.2.3. By Technology
            17.2.2.4. By End User
    17.3. Brazil
        17.3.1. Pricing Analysis
        17.3.2. Market Share Analysis, 2022
            17.3.2.1. By Product
            17.3.2.2. By Route of Administration
            17.3.2.3. By Technology
            17.3.2.4. By End User
    17.4. Mexico
        17.4.1. Pricing Analysis
        17.4.2. Market Share Analysis, 2022
            17.4.2.1. By Product
            17.4.2.2. By Route of Administration
            17.4.2.3. By Technology
            17.4.2.4. By End User
    17.5. Germany
        17.5.1. Pricing Analysis
        17.5.2. Market Share Analysis, 2022
            17.5.2.1. By Product
            17.5.2.2. By Route of Administration
            17.5.2.3. By Technology
            17.5.2.4. By End User
    17.6. France
        17.6.1. Pricing Analysis
        17.6.2. Market Share Analysis, 2022
            17.6.2.1. By Product
            17.6.2.2. By Route of Administration
            17.6.2.3. By Technology
            17.6.2.4. By End User
    17.7. Italy
        17.7.1. Pricing Analysis
        17.7.2. Market Share Analysis, 2022
            17.7.2.1. By Product
            17.7.2.2. By Route of Administration
            17.7.2.3. By Technology
            17.7.2.4. By End User
    17.8. Spain
        17.8.1. Pricing Analysis
        17.8.2. Market Share Analysis, 2022
            17.8.2.1. By Product
            17.8.2.2. By Route of Administration
            17.8.2.3. By Technology
            17.8.2.4. By End User
    17.9. The United Kingdom
        17.9.1. Pricing Analysis
        17.9.2. Market Share Analysis, 2022
            17.9.2.1. By Product
            17.9.2.2. By Route of Administration
            17.9.2.3. By Technology
            17.9.2.4. By End User
    17.10. BENELUX
        17.10.1. Pricing Analysis
        17.10.2. Market Share Analysis, 2022
            17.10.2.1. By Product
            17.10.2.2. By Route of Administration
            17.10.2.3. By Technology
            17.10.2.4. By End User
    17.11. Russia
        17.11.1. Pricing Analysis
        17.11.2. Market Share Analysis, 2022
            17.11.2.1. By Product
            17.11.2.2. By Route of Administration
            17.11.2.3. By Technology
            17.11.2.4. By End User
    17.12. Poland
        17.12.1. Pricing Analysis
        17.12.2. Market Share Analysis, 2022
            17.12.2.1. By Product
            17.12.2.2. By Route of Administration
            17.12.2.3. By Technology
            17.12.2.4. By End User
    17.13. China
        17.13.1. Pricing Analysis
        17.13.2. Market Share Analysis, 2022
            17.13.2.1. By Product
            17.13.2.2. By Route of Administration
            17.13.2.3. By Technology
            17.13.2.4. By End User
    17.14. ASIAN
        17.14.1. Pricing Analysis
        17.14.2. Market Share Analysis, 2022
            17.14.2.1. By Product
            17.14.2.2. By Route of Administration
            17.14.2.3. By Technology
            17.14.2.4. By End User
    17.15. Australia
        17.15.1. Pricing Analysis
        17.15.2. Market Share Analysis, 2022
            17.15.2.1. By Product
            17.15.2.2. By Route of Administration
            17.15.2.3. By Technology
            17.15.2.4. By End User
    17.16. Japan
        17.16.1. Pricing Analysis
        17.16.2. Market Share Analysis, 2022
            17.16.2.1. By Product
            17.16.2.2. By Route of Administration
            17.16.2.3. By Technology
            17.16.2.4. By End User
    17.17. GCC Countries
        17.17.1. Pricing Analysis
        17.17.2. Market Share Analysis, 2022
            17.17.2.1. By Product
            17.17.2.2. By Route of Administration
            17.17.2.3. By Technology
            17.17.2.4. By End User
    17.18. South Africa
        17.18.1. Pricing Analysis
        17.18.2. Market Share Analysis, 2022
            17.18.2.1. By Product
            17.18.2.2. By Route of Administration
            17.18.2.3. By Technology
            17.18.2.4. By End User
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Product
        18.3.3. By Route of Administration
        18.3.4. By Technology
        18.3.5. By End User
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. Pyng Medical Corp.
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
                19.1.1.5.2. Product Strategy
                19.1.1.5.3. Channel Strategy
        19.1.2. Cook Medical Incorporated
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
                19.1.2.5.2. Product Strategy
                19.1.2.5.3. Channel Strategy
        19.1.3. PerSys Medical
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
                19.1.3.5.2. Product Strategy
                19.1.3.5.3. Channel Strategy
        19.1.4. Aero Healthcare
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
                19.1.4.5.2. Product Strategy
                19.1.4.5.3. Channel Strategy
        19.1.5. Teleflex, Inc.
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
                19.1.5.5.2. Product Strategy
                19.1.5.5.3. Channel Strategy
        19.1.6. Becton Dickinson and Co.
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
                19.1.6.5.2. Product Strategy
                19.1.6.5.3. Channel Strategy
        19.1.7. Biopsybell
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
                19.1.7.5.2. Product Strategy
                19.1.7.5.3. Channel Strategy
        19.1.8. Pavmed
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
                19.1.8.5.2. Product Strategy
                19.1.8.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Recommendations

Healthcare

Intraosseous Devices Market

November 2022

REP-GB-1516

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Intraosseous Infusion Devices Market

Schedule a Call